๐ฐ Eceptor News
Page 3 - Eceptor News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eceptor. Real-time updates on events, politics, business and more.
April 1, 2024
Study reveals that learning triggers a series of molecular events including DNA damage and repair in hippocampal neurons, mediated by TLR9, crucial for memory formation.
April 1, 2024
Study investigates the transcriptomic changes in human vascular smooth muscle cells exposed to spaceflight, revealing significant alterations in gene expression affecting cellular function and phenotype.
March 29, 2024
On March 26th, the US FDA granted approval for Merckโs WINREVAIRโข (sotatercept-csrk), marking a significant milestone in pulmonary arterial hypertension (PAH) treatment. PAH, characterized by elevated blood pressure in the arteries connecting the heart and lungs, poses a grave risk of heart failure.
March 28, 2024
A team of researchers from Hiroshima University has discovered a molecule that promotes the production of cancer cells. This molecule may prove to be a potential therapeutic target in the treatment of triple-negative breast cancer, an aggressive form of breast cancer.
March 27, 2024
Two plant compounds with potential as GLP-1 agonist weight loss pills have been identified in an AI (artificial intelligence)-based study, the European Congress on Obesity (ECO 2024) (Venice 12-15 May), will hear.
March 27, 2024
Lung cancer is the leading cause of cancer-related death worldwide. Improved understanding of driver mutations of non-small cell lung cancer (NSCLC) has led to more biomarker-directed treatment for patients with advanced stages.
March 25, 2024
Research highlights the inflammatory impacts of ARDS on the heart, underscoring the role of immune responses in cardiovascular complications from viral infections, including COVID-19, and emphasizes the potential of TNF-ฮฑ neutralizing therapy to mitigate these effects.
March 13, 2024
Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this extremely common virus.
March 12, 2024
A new study highlights a potential therapeutic target for immune-related disorders, such as multiple sclerosis and asthma.
March 12, 2024
Genetic heterogeneity of blood pressure (BP) effects between sexes.